These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24258990)

  • 1. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
    Rashid AB; Grossniklaus HE
    Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects for developing treatment of uveal melanoma from the position of modern carcinogenesis concepts].
    Likhvantseva VG
    Vestn Oftalmol; 2002; 118(1):32-5. PubMed ID: 11898358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
    Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
    JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases of bilateral uveal melanoma].
    Saakian SV; Iurovskaia NN; Miakoshina EB
    Vestn Oftalmol; 2011; 127(3):31-6. PubMed ID: 21800723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells in uveal melanoma.
    Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
    Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal melanoma: diagnostic features.
    Biscotti CV; Singh AD
    Monogr Clin Cytol; 2012; 21():44-54. PubMed ID: 22024583
    [No Abstract]   [Full Text] [Related]  

  • 9. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical assessment of mitotic count in uveal melanoma.
    Angi M; Damato B; Kalirai H; Dodson A; Taktak A; Coupland SE
    Acta Ophthalmol; 2011 Mar; 89(2):e155-60. PubMed ID: 19900200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal MALT lymphoma with extensive AL-type amyloid production mimicking uveal melanoma.
    Haq I; Rundle PA; Gilbertson JA; Wechalekar AD; Mudhar HS
    Histopathology; 2015 Mar; 66(4):607-10. PubMed ID: 24853590
    [No Abstract]   [Full Text] [Related]  

  • 13. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
    Anurova OA; Likhvantseva VG; Vereshchagina MV
    Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
    Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MET expression in primary and liver metastases in uveal melanoma.
    Gardner FP; Serie DJ; Salomao DR; Wu KJ; Markovic SN; Pulido JS; Joseph RW
    Melanoma Res; 2014 Dec; 24(6):617-20. PubMed ID: 25211165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
    Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
    Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
    Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.